These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 18024881

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E, Ma H, McKean-Cowdin R, Van Den Berg D, Bernstein L, Henderson BE, Ursin G.
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.
    Brohet RM, Goldgar DE, Easton DF, Antoniou AC, Andrieu N, Chang-Claude J, Peock S, Eeles RA, Cook M, Chu C, Noguès C, Lasset C, Berthet P, Meijers-Heijboer H, Gerdes AM, Olsson H, Caldes T, van Leeuwen FE, Rookus MA.
    J Clin Oncol; 2007 Sep 01; 25(25):3831-6. PubMed ID: 17635951
    [Abstract] [Full Text] [Related]

  • 5. Oral contraceptive use and BRCA penetrance: a case-only study.
    Pasanisi P, Hédelin G, Berrino J, Chang-Claude J, Hermann S, Steel M, Haites N, Hart J, Peled R, Gafà L, Leggio L, Traina A, Amodio R, Primic-Zakelj M, Zadnik V, Veidebaum T, Tekkel M, Berrino F.
    Cancer Epidemiol Biomarkers Prev; 2009 Jul 01; 18(7):2107-13. PubMed ID: 19549808
    [Abstract] [Full Text] [Related]

  • 6. Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Hopper JL, Baron JA.
    J Natl Cancer Inst; 2003 Jul 02; 95(13):1010-1; author reply 1012-3. PubMed ID: 12837841
    [No Abstract] [Full Text] [Related]

  • 7. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group.
    J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670
    [Abstract] [Full Text] [Related]

  • 8. Can genetic testing guide treatment in breast cancer?
    Tutt A, Ashworth A.
    Eur J Cancer; 2008 Dec 05; 44(18):2774-80. PubMed ID: 19027287
    [Abstract] [Full Text] [Related]

  • 9. Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.
    Fuller S, Liebens F, Carly B, Pastijn A, Rozenberg S.
    Breast J; 2008 Dec 05; 14(6):603-4. PubMed ID: 19054005
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer.
    Hashemian AH, Hajizadeh E, Kazemnejad A, Atri M, Mehdipour P.
    Saudi Med J; 2009 Jan 05; 30(1):41-4. PubMed ID: 19139771
    [Abstract] [Full Text] [Related]

  • 12. Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Rookus MA, Brohet R, van Leeuwen FE.
    J Natl Cancer Inst; 2003 Jul 02; 95(13):1012. PubMed ID: 12837843
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisinger F, Huiart L.
    J Natl Cancer Inst; 2009 Feb 18; 101(4):277; author reply 277-8. PubMed ID: 19211447
    [No Abstract] [Full Text] [Related]

  • 15. Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
    Biglia N, Mariani L, Ponzone R, Sismondi P.
    Maturitas; 2008 Jun 20; 60(2):71-7. PubMed ID: 18472232
    [No Abstract] [Full Text] [Related]

  • 16. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
    Kotsopoulos J, Librach CL, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Randall S, Manoukian S, Pasini B, Tung N, Ainsworth PJ, Cummings S, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.
    Cancer Causes Control; 2008 Dec 20; 19(10):1111-9. PubMed ID: 18509731
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2009 May 20; 115(1):51-5. PubMed ID: 18483852
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.